Sunshine Biopharma, Inc. (SBFM)
USD 2.75
(0.37%)
USD 2.75
(0.37%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -370.41 USD | 89.49% |
| 2022 | -3523.64 USD | 63.95% |
| 2021 | -9774.32 USD | -842.93% |
| 2020 | -1036.59 USD | -25.19% |
| 2019 | -828.01 USD | -485.0% |
| 2018 | -141.54 USD | -493.71% |
| 2017 | -23.84 USD | 85.52% |
| 2016 | -164.63 USD | 39.13% |
| 2015 | -270.44 USD | 48.6% |
| 2014 | -526.17 USD | 36.39% |
| 2013 | -827.19 USD | -200.05% |
| 2012 | -275.68 USD | -20.74% |
| 2011 | -228.33 USD | 34.91% |
| 2010 | -350.77 USD | 0.0% |
| 2009 | - USD | 100.0% |
| 2008 | -66.46 USD | -137.02% |
| 2007 | -28.04 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -9.94 USD | 75.17% |
| 2024 Q1 | -40.04 USD | 61.75% |
| 2023 Q3 | -50.72 USD | -7043.66% |
| 2023 Q1 | -154.51 USD | -14615.24% |
| 2023 Q2 | -0.71 USD | 99.54% |
| 2023 Q4 | -104.69 USD | -106.41% |
| 2023 FY | - USD | 89.49% |
| 2022 Q4 | -1.05 USD | 86.38% |
| 2022 Q2 | -2.41 USD | 69.18% |
| 2022 FY | - USD | 63.95% |
| 2022 Q1 | -7.82 USD | -1303.08% |
| 2022 Q3 | -7.71 USD | -219.92% |
| 2021 Q3 | -26.48 USD | -32.0% |
| 2021 Q1 | -46.99 USD | -630.79% |
| 2021 Q4 | 0.65 USD | 102.45% |
| 2021 Q2 | -20.06 USD | 57.31% |
| 2021 FY | - USD | -842.93% |
| 2020 FY | - USD | -25.19% |
| 2020 Q4 | -6.43 USD | -54.94% |
| 2020 Q2 | -3.48 USD | -596.0% |
| 2020 Q3 | -4.15 USD | -19.25% |
| 2020 Q1 | -0.50 USD | 76.3% |
| 2019 FY | - USD | -485.0% |
| 2019 Q1 | -2.35 USD | 40.51% |
| 2019 Q2 | -7.15 USD | -204.26% |
| 2019 Q3 | -2.12 USD | 70.35% |
| 2019 Q4 | -2.11 USD | 0.47% |
| 2018 FY | - USD | -493.71% |
| 2018 Q4 | -3.95 USD | 78.24% |
| 2018 Q3 | -18.15 USD | -40.92% |
| 2018 Q2 | -12.88 USD | -128.37% |
| 2018 Q1 | -5.64 USD | -22.61% |
| 2017 Q4 | -4.60 USD | -41.54% |
| 2017 Q3 | -3.25 USD | 71.29% |
| 2017 Q2 | -11.32 USD | -132.92% |
| 2017 Q1 | -4.86 USD | 83.37% |
| 2017 FY | - USD | 85.52% |
| 2016 Q4 | -29.23 USD | 75.82% |
| 2016 FY | - USD | 39.13% |
| 2016 Q3 | -120.89 USD | -229.4% |
| 2016 Q2 | -36.70 USD | -29.54% |
| 2016 Q1 | -28.33 USD | 52.85% |
| 2015 Q2 | -86.37 USD | -50.23% |
| 2015 Q3 | -31.20 USD | 63.88% |
| 2015 Q4 | -60.08 USD | -92.56% |
| 2015 FY | - USD | 48.6% |
| 2015 Q1 | -57.49 USD | 31.99% |
| 2014 Q3 | -81.55 USD | 67.16% |
| 2014 FY | - USD | 36.39% |
| 2014 Q2 | -248.30 USD | -55.15% |
| 2014 Q4 | -84.53 USD | -3.65% |
| 2014 Q1 | -160.04 USD | 29.71% |
| 2013 Q2 | -54.24 USD | 89.69% |
| 2013 Q1 | -526.06 USD | -615.63% |
| 2013 Q4 | -227.68 USD | -263.13% |
| 2013 FY | - USD | -200.05% |
| 2013 Q3 | -62.70 USD | -15.6% |
| 2012 Q3 | -146.72 USD | -250.17% |
| 2012 Q2 | -41.90 USD | -159.44% |
| 2012 Q4 | -73.51 USD | 49.9% |
| 2012 Q1 | -16.15 USD | 89.43% |
| 2012 FY | - USD | -20.74% |
| 2011 Q4 | -152.73 USD | -103.04% |
| 2011 Q3 | -75.22 USD | -599.07% |
| 2011 Q1 | -32.13 USD | 86.94% |
| 2011 FY | - USD | 34.91% |
| 2011 Q2 | -10.76 USD | 66.51% |
| 2010 Q2 | -1015.38 USD | -1675.14% |
| 2010 Q4 | -246.05 USD | 42.8% |
| 2010 FY | - USD | 0.0% |
| 2010 Q3 | -430.12 USD | 57.64% |
| 2010 Q1 | -57.20 USD | 0.0% |
| 2009 FY | - USD | 100.0% |
| 2009 Q3 | -724.51 USD | -3768.18% |
| 2009 Q2 | -18.73 USD | -49.12% |
| 2009 Q1 | -12.56 USD | -55.06% |
| 2008 Q3 | -14.06 USD | -16.87% |
| 2008 Q4 | -8.10 USD | 42.39% |
| 2008 FY | - USD | -137.02% |
| 2008 Q1 | -30.81 USD | -536.57% |
| 2008 Q2 | -12.03 USD | 60.95% |
| 2007 Q4 | -4.84 USD | 74.23% |
| 2007 FY | - USD | 0.0% |
| 2007 Q3 | -18.78 USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Theratechnologies Inc. | -0.91 USD | -40604.396% |
| Harrow Health, Inc. | -0.75 USD | -49288.0% |
| Dynavax Technologies Corporation | -0.05 USD | -746694.355% |
| Biofrontera Inc. | -13.02 USD | -2744.931% |
| Cronos Group Inc. | -0.19 USD | -194852.632% |
| Sonoma Pharmaceuticals, Inc. | -10.64 USD | -3381.297% |
| Ironwood Pharmaceuticals, Inc. | -6.45 USD | -5642.791% |
| Kala Pharmaceuticals, Inc. | -17.35 USD | -2034.928% |
| RedHill Biopharma Ltd. | 3.69 USD | 10138.211% |
| Cumberland Pharmaceuticals Inc. | -0.44 USD | -84084.091% |
| Radius Health, Inc. | -0.92 USD | -40161.957% |
| Universe Pharmaceuticals INC | -1.70 USD | -21688.824% |
| DURECT Corporation | -1.22 USD | -30261.475% |
| ProPhase Labs, Inc. | -0.98 USD | -37696.939% |
| Safety Shot Inc | -0.48 USD | -77068.75% |
| Phibro Animal Health Corporation | 0.06 USD | 621593.289% |
| China SXT Pharmaceuticals, Inc. | -3.57 USD | -10275.63% |
| Alvotech | -2.43 USD | -15143.21% |
| Assertio Holdings, Inc. | -4.67 USD | -7831.692% |
| Supernus Pharmaceuticals, Inc. | 0.02 USD | 1537070.954% |
| Rockwell Medical, Inc. | -0.36 USD | -102791.667% |
| Procaps Group S.A. | 0.42 USD | 88292.857% |
| Intra-Cellular Therapies, Inc. | -1.46 USD | -25270.548% |
| SCYNEXIS, Inc. | 1.40 USD | 26557.857% |
| Aytu BioPharma, Inc. | -2.86 USD | -12851.399% |
| Viatris Inc. | 0.05 USD | 812402.632% |
| OptiNose, Inc. | -0.32 USD | -115653.125% |
| SIGA Technologies, Inc. | 0.95 USD | 39090.526% |
| Tilray Brands, Inc. | -0.33 USD | -112145.455% |
| PetIQ, Inc. | 0.07 USD | 506816.826% |
| Sunshine Biopharma, Inc. | -370.41 USD | -0.0% |
| Neurocrine Biosciences, Inc. | 2.56 USD | 14569.141% |
| Guardion Health Sciences, Inc. | 0.12 USD | 308775.0% |
| Alimera Sciences, Inc. | -0.79 USD | -46787.342% |
| Collegium Pharmaceutical, Inc. | 1.60 USD | 23250.625% |
| Silver Spike Investment Corp. | 1.18 USD | 31490.678% |
| Shuttle Pharmaceuticals Holdings, Inc. | -0.41 USD | -90243.902% |
| Organogenesis Holdings Inc. | 0.04 USD | 982619.894% |
| Journey Medical Corporation | -0.21 USD | -176285.714% |
| Petros Pharmaceuticals, Inc. | -6.35 USD | -5733.228% |
| Alpha Teknova, Inc. | -1.16 USD | -31831.897% |
| Clever Leaves Holdings Inc. | -11.42 USD | -3143.52% |
| Lifecore Biomedical, Inc. | 0.39 USD | 95076.923% |
| PainReform Ltd. | -42.86 USD | -764.232% |
| Cosmos Health Inc. | -2.15 USD | -17128.372% |
| Avadel Pharmaceuticals plc | -2.00 USD | -18420.5% |
| TherapeuticsMD, Inc. | -0.55 USD | -67247.273% |
| Embecta Corp. | 1.23 USD | 30214.634% |
| Regencell Bioscience Holdings Limited | -0.33 USD | -112145.455% |
| Talphera, Inc. | -1.29 USD | -28613.953% |
| Pacira BioSciences, Inc. | 0.91 USD | 40804.396% |
| Incannex Healthcare Limited | -1.14 USD | -32392.105% |
| Cyclo Therapeutics, Inc. | -1.23 USD | -30014.634% |
| Shineco, Inc. | -4.22 USD | -8677.488% |
| Procaps Group, S.A. | 0.42 USD | 88292.857% |
| ANI Pharmaceuticals, Inc. | 0.95 USD | 39090.526% |
| Aquestive Therapeutics, Inc. | -0.13 USD | -284830.769% |
| Lantheus Holdings, Inc. | 4.79 USD | 7832.985% |
| Alvotech | -2.43 USD | -15143.21% |
| Hempacco Co., Inc. | -4.70 USD | -7781.064% |
| Eagle Pharmaceuticals, Inc. | 2.76 USD | 13520.652% |
| Bright Green Corporation | -0.07 USD | -503859.184% |
| Esperion Therapeutics, Inc. | -2.03 USD | -18146.798% |
| Kamada Ltd. | 0.17 USD | 217988.235% |
| Indivior PLC | 0.01 USD | 2537154.795% |
| Evoke Pharma, Inc. | -27.97 USD | -1224.312% |
| Flora Growth Corp. | -7.33 USD | -4953.342% |
| Cyclo Therapeutics, Inc. | -1.23 USD | -30014.634% |
| Evolus, Inc. | -1.08 USD | -34197.222% |
| HUTCHMED (China) Limited | 0.59 USD | 62881.356% |
| Amphastar Pharmaceuticals, Inc. | 2.85 USD | 13096.842% |
| Akanda Corp. | -7.16 USD | -5073.324% |